中新集團(601512.SH):擬以不超6000萬元參投蘇州道彤騰輝創業投資合夥企業
格隆匯12月29日丨中新集團(601512.SH)公佈,公司擬作為有限合夥人以自有資金參與投資蘇州道彤騰輝創業投資合夥企業(有限合夥)(“標的基金”),公司認繳出資不超過6000萬元,且佔比不超過最終基金認繳總額的10%。
標的基金專注於對中國境內健康醫療養老相關領域以及科技、傳媒和通訊(“TMT”)領域的早期項目進行直接或間接的股權或準股權投資或從事與投資相關的活動。除此之外,合夥企業的資金亦可用於:因新技術、新商業模式帶來的生活方式變革而隨之產生的新興行業相關領域的早期投資。
該基金於2020年9月完成工商註冊,已於2021年2月7日完成中基協備案(備案號:SLX587),首次關閉規模為2.8億元。標的基金本輪擬主要引進多家機構投資者,目標規模為8-10億元,最終以實際募集情況為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.